Cardiovascular Diseases

CETP Gene Variants Not Associated with CVD Risk

A prospective biobank study concluded that genetic variants of cholesteryl ester transfer protein (CETP) were associated with altered high-density lipoprotein (HDL) metabolism but not lower low-density lipoprotein (LDL) cholesterol levels and had no significant association with risk for cardiovascular disease (CVD). The study included 151 217 individuals aged 30 to 79 years in China from June 25, 2004, through July 15, 2008. Median follow-up of 9.2 years was completed January 1, 2016. Five CETP variants were combined in a genetic score and were strongly associated with higher concentrations of HDL cholesterol but not lower LDL cholesterol levels. When scaled to 10-mg/dL higher levels of HDL cholesterol, the CETP genetic score was not associated with occlusive CVD, major coronary events, myocardial infarction, ischemic stroke, intracerebral hemorrhage, or other vascular diseases or carotid plaque. The results suggest that in the absence of reduced LDL cholesterol levels, increasing HDL cholesterol levels by inhibition of CETP may not confer significant benefits for CVD. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Dose Response of Physical Activity in CVD and Mortality

Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…

1 day ago

Faster Walking Pace May Reduce Risk of Cardiac Arrhythmias

A prospective UK cohort study found that both self-reported average or brisk walking pace and…

2 days ago

4:3 Intermittent Fasting Outperforms Daily Caloric Restriction for Weight Loss

A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…

4 weeks ago

Comparative CVD Efficacy of Newer Glucose-Lowering Drugs in Elderly T2D Patients

A Danish nationwide cohort study provided real world evidence that both glucagon-like peptide 1 receptor…

1 month ago

Efficacy of Non-Surgical and Non-Interventional Treatments in Low Back Pain

A systematic review and meta-analysis of placebo-controlled randomized trials showed that there is moderate certainty…

1 month ago

Statin Use Linked to Lower Risks of HCC and Liver Disease Progression

A US cohort study indicated that statin use may reduce the risks of hepatocellular carcinoma…

1 month ago

This website uses cookies.